IP Library Granted Patent US 11,208,627
Granted Patent B2
US 11,208,627 · App. 16/250,457 · Granted Dec 28, 2021

Augmented biocontainment materials and augmented biocontainment enclosures

Inventors: Peter D. Gabriele (Frisco, TX); Jeremy J. Harris (Doylestown, PA); Charles Brendan Nicholson (Perkasie, PA); Steven Lu (Ambler, PA); Jeffrey H. Robertson (Sellersville, PA); Gael Peron (Winston-Salem, NC)
Assignee: THE SECANT GROUP, LLC
C12N5/0068C12M23/14C12M23/20C12M23/26C12M23/28C12M23/52C12M25/14C12M41/46C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,208,627
App. No.
16/250,457
Granted
Dec 28, 2021
Kind
B2
Abstract

A biocontainment vessel includes a vessel structure including a structural composition and an enhancement composition associated with the structural composition. The enhancement composition includes a co-polymer. The co-polymer is a poly(glycerol sebacate) or a poly(glycerol sebacate urethane). The enhancement composition may also include an augmentation agent associated with the co-polymer. The enhancement composition is located with respect to the structural composition such that the enhancement composition benefits biological cells contained in the biocontainment vessel. A composition includes a co-polymer and an augmentation agent contained by the co-polymer. A method of containing biological cells includes placing the biological cells in an augmented biocontainment vessel and storing them in the augmented biocontainment vessel under predetermined conditions. An augmented substrate includes a substrate and an enhancement composition coating a surface of the substrate.

Claims (36)

1. A biocontainment vessel comprising:

a vessel structure comprising:

a structural composition; and

an enhancement composition associated with the structural composition, the enhancement composition comprising a co-polymer selected from the group consisting of a poly(glycerol sebacate) and a poly(glycerol sebacate urethane) and an augmentation agent physically mixed with or chemically attached to the co-polymer, wherein the augmentation agent is selected from the group consisting of a 2-3-diphosphoglycerate scavenger, a composition protecting against hemoglobin scavenging of nitrous oxide, an affinity composition for toxins, a fiber extrudate, a paramagnetic material, a lactic acid scavenger, a cell preservation composition, a sanitation composition, a surface passivation composition, and combinations thereof.

2. The biocontainment vessel of claim 1 , wherein the structural composition comprises polyvinyl chloride.

3. The biocontainment vessel of claim 1 , wherein the enhancement composition is located on a surface of the structural composition on a containment side of the vessel structure.

4. The biocontainment vessel of claim 3 further comprising an inner film layer on a surface of the enhancement composition on a containment side of the vessel structure.

5. The biocontainment vessel of claim 1 , wherein the enhancement composition is a plasticizer mixed with the structural composition.

6. The biocontainment vessel of claim 1 , wherein the co-polymer is poly(glycerol sebacate).

7. The biocontainment vessel of claim 1 , wherein the co-polymer is poly(glycerol sebacate urethane).

8. The biocontainment vessel of claim 1 , wherein the enhancement composition is located with respect to the structural composition such that the augmentation agent benefits biological cells contained in the biocontainment vessel.

9. A method of containing biological cells, the method comprising:

placing the biological cells in the augmented biocontainment vessel of claim 1 ; and

storing the biological cells in the augmented biocontainment vessel under predetermined conditions.

10. The method of claim 9 , wherein the co-polymer is poly(glycerol sebacate).

11. The method of claim 9 , wherein the co-polymer is poly(glycerol sebacate urethane).

12. The method of claim 9 , wherein the enhancement composition is located with respect to the structural composition such that the augmentation agent benefits the biological cells contained in the biocontainment vessel.

13. A composition comprising:

a co-polymer selected from the group consisting of a poly(glycerol sebacate) and a poly(glycerol sebacate urethane); and

an augmentation agent physically mixed with or chemically attached to the co-polymer, wherein the augmentation agent is selected from the group consisting of a 2-3-diphosphoglycerate scavenger, a composition protecting against hemoglobin scavenging of nitrous oxide, an affinity composition for toxins, a fiber extrudate, a paramagnetic material, a lactic acid scavenger, a cell preservation composition, a sanitation composition, a surface passivation composition, and combinations thereof.

14. The composition of claim 13 , wherein the co-polymer is poly(glycerol sebacate).

15. The composition of claim 13 , wherein the co-polymer is poly(glycerol sebacate urethane).

16. The composition of claim 13 , wherein the augmentation agent is physically mixed with the co-polymer.

17. The composition of claim 13 , wherein the augmentation agent is chemically attached to the co-polymer.

18. An augmented substrate comprising:

a substrate; and

an enhancement composition coating a surface of the substrate, the enhancement composition comprising a co-polymer selected from the group consisting of a poly(glycerol sebacate) and a poly(glycerol sebacate urethane) and an augmentation agent physically mixed with or chemically attached to the co-polymer, wherein the augmentation agent is selected from the group consisting of a 2-3-diphosphoglycerate scavenger, a composition protecting against hemoglobin scavenging of nitrous oxide, an affinity composition for toxins, a fiber extrudate, a paramagnetic material, a lactic acid scavenger, a cell preservation composition, a sanitation composition, a surface passivation composition, and combinations thereof.

19. The composition of claim 13 , wherein the augmentation agent comprises a 2-3-diphosphoglycerate scavenger.

20. The composition of claim 13 , wherein the augmentation agent comprises a composition protecting against hemoglobin scavenging of nitrous oxide.

21. The composition of claim 13 , wherein the augmentation agent comprises an affinity composition for toxins.

22. The composition of claim 13 , wherein the augmentation agent comprises a fiber extrudate.

23. The composition of claim 13 , wherein the augmentation agent comprises a paramagnetic material.

24. The composition of claim 13 , wherein the augmentation agent comprises a lactic acid scavenger.

25. The composition of claim 13 , wherein the augmentation agent comprises a cell preservation composition.

26. The composition of claim 13 , wherein the augmentation agent comprises a sanitation composition.

27. The composition of claim 13 , wherein the augmentation agent comprises a surface passivation composition.

Assignments (2)
SECURITY INTEREST Recorded May 28, 2021
From: THE SECANT GROUP, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 056421/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2019
From: GABRIELE, PETER D.; HARRIS, JEREMY J.; NICHOLSON, CHARLES BRENDAN; LU, STEVEN; ROBERTSON, JEFFREY H.; PERON, GAEL
To: THE SECANT GROUP, LLC
Reel/Frame 048217/0574 →
Continuity (2)
Provisional Application 62618419 · Jan 17, 2018
Related Publication 20190218507A1 · Jul 18, 2019